| Literature DB >> 26179532 |
Norihiko Ohashi1, Takenori Okada, Mio Uchida, Michitaka Amioka, Mai Fujiwara, Shunichi Kaseda.
Abstract
Left ventricular thrombus (LVT) after acute myocardial infarction (AMI) is a risk factor for embolic complications. Although warfarin has traditionally been used to treat LVT, it has relevant disadvantages that limit its use. We herein describe the case of a 78-year-old man with AMI who had a history of paroxysmal atrial fibrillation. Following 10 days of urgent coronary reperfusion therapy, transthoracic echocardiography revealed a moderately sized LVT in the apex, which subsequently disappeared after 18 days of treatment with dabigatran. This case demonstrates that dabigatran may represent an alternative to warfarin as a therapeutic option in patients with LVT after AMI.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26179532 DOI： 10.2169/internalmedicine.54.4191
Source DB: PubMed Journal: Intern Med ISSN： 0918-2918 Impact factor: 1.271